Amgen, Inc. AMGN shares are trading higher on Monday after receiving an upgrade.
Raymond James analyst Dane Leone upgraded the stock from Market Perform to Outperform and announced a $255 price target.
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Amgen's shares were trading up 4% to $206.34 at time of publication. The stock has a 52-week high of $244.99 and a 52-week low of $166.30.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
